XML 77 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Revenue from Contracts with Customers
3 Months Ended
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers

3.   Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 1 to our consolidated financial statements in Item 8 of the 2023 Annual Report on Form 10-K.

Disaggregation of Revenue

Our revenue is disaggregated based on reporting segment, product category and geographical region. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.

The following table presents revenue from contracts with customers by reporting segment, product category and geographical region for the three-month periods ended March 31, 2024 and 2023 (in thousands):

Three Months Ended

Three Months Ended

March 31, 2024

March 31, 2023

    

United States

    

International

    

Total

    

United States

    

International

    

Total

Cardiovascular

 

  

 

 

  

 

  

 

  

 

  

Peripheral Intervention

$

79,259

$

55,367

$

134,626

$

68,667

$

45,116

$

113,783

Cardiac Intervention

 

35,343

55,345

 

90,688

 

34,305

51,023

 

85,328

Custom Procedural Solutions

 

29,294

19,500

 

48,794

 

26,799

20,902

 

47,701

OEM

 

32,649

6,617

 

39,266

 

32,564

8,600

 

41,164

Total

 

176,545

136,829

 

313,374

 

162,335

 

125,641

 

287,976

 

Endoscopy

Endoscopy Devices

 

9,549

 

585

 

10,134

 

9,025

 

564

 

9,589

Total

$

186,094

$

137,414

$

323,508

$

171,360

$

126,205

$

297,565